About Trident Lifeline Limited
Data last updated: 24 December 2025
Trident Lifeline Limited is a public limited company based in Surat, Gujarat, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 09 January 2014, the company has been in operation for over 12 years.
Registered with ROC Ahmedabad under CIN L51909GJ2014PLC078227. Listed.
Capital: an authorised share capital of ₹15 Cr and a paid-up capital of ₹11.8 Cr. It is led by directors including Mishal Shailesh Patel and Shravan H Patel.
Last AGM: 20 September 2024. Financial statements filed for year ended 31 March 2024. Office: 2Nd Floor Shop – 2004 North Extension Falsawadi Begumpura Nodh – 4/1650 Sahara Darwaja, Surat, Gujarat, India – 395003.
As per the financials filed for FY 2024, the company reported a revenue of ₹46.71 Cr, a growth of 42% compared to the previous year.
The company has a workforce of approximately 27 employees as per the latest available data. Its group structure includes 1 subsidiary.
The company is associated with 1 brand - Trident Lifeline. As per MCA filings, the company has open charges of ₹102.81 Cr and satisfied charges of ₹1.58 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website tridentlifeline.com.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media
-
Registered Address2Nd Floor Shop – 2004 North Extension Falsawadi Begumpura Nodh – 4/1650 Sahara Darwaja, Surat, Gujarat, India – 395003
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Trident Lifeline Limited
Trident Lifeline Limited has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L51909GJ2014PLC078227, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L51909GJ2014PLC078227 | Current |
| U51909GJ2014PTC078227 | Previous |
| U51909GJ2014PLC078227 | Previous |
Associated Brands with Trident Lifeline Limited
Trident Lifeline Limited operates one associated brand: Trident Lifeline. These brands represent Trident Lifeline Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Manufacturer of liquid orals, topical preparations, capsule, and other drugs | tridentlifeline.com |
Business Activity of Trident Lifeline Limited
Trident Lifeline Limited is engaged in the principal business activity of trade, with detailed activities including wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | ********* |
Auditor Details of Trident Lifeline Limited
Trident Lifeline Limited is audited by A BAFNA & ASSOCIATES (ICAI peer reviewed, certificate valid till 2027-04-30) for the financial year 2026, as reported in its BSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| A BAFNA & ASSOCIATES (ICAI peer reviewed, certificate valid till 2027-04-30) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Trident Lifeline Limited
Trident Lifeline Limited is currently managed by 7 directors, with 12 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Mishal Shailesh Patel
Also directs:
Trident Texofab Limited, Trident Lifeline Limited
|
Director | 22 Jul 2023 | 2 Years 11 Months | Current |
| Shravan H Patel | Managing Director | 04 Jul 2022 | 4 Years 0 Months | Current |
|
Falguni Bhavesh Jariwala
Also directs:
Trident Lifeline Limited
|
Director | 27 Apr 2024 | 2 Years 2 Months | Current |
| Hardik Jigishkumar Desai | Director | 27 Jun 2022 | 4 Years 0 Months | Current |
| Rupaben Chetanbhai Jariwala | Whole-Time Director | 16 May 2024 | 2 Years 1 Months | Current |
|
Ashish Anandsingh Bafna
Also directs:
Trident Lifeline Limited, Tll Ventures Private Limited
|
Director | 01 Sep 2025 | 0 Years 10 Months | Current |
Financials of Trident Lifeline Limited FY 2026 filings available
Trident Lifeline Limited reported revenue of ₹129.02 Cr (up 48.36% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Revenue from Operations | ₹129.02 Cr | ₹86.96 Cr | ₹44.63 Cr | ₹31.69 Cr |
| Other Income | ₹9.27 Cr | ₹8.23 Cr | ₹2.08 Cr | ₹1.16 Cr |
| Total Income | ₹138.29 Cr | ₹95.2 Cr | - | - |
| Cost of Materials Consumed | ₹59.94 Cr | ₹43.05 Cr | ₹21.12 Cr | ₹12.19 Cr |
| Purchases of Stock-in-Trade | ₹9.17 Cr | ₹1.8 Cr | ₹9.46 Cr | ₹10.93 Cr |
| Changes in Inventories | ₹7.35 Cr | ₹71 Lakh | -₹1.23 Cr | -₹2.89 Cr |
| Employee Benefit Expense | ₹10.78 Cr | ₹12.09 Cr | ₹2.4 Cr | ₹1.61 Cr |
| Finance Costs | ₹4.12 Cr | ₹3.99 Cr | ₹60.44 Lakh | ₹46.59 Lakh |
| Other Expenses | ₹13.67 Cr | ₹14.46 Cr | ₹4.69 Cr | ₹3.61 Cr |
| Total Expenses | ₹111.1 Cr | ₹81.58 Cr | ₹38.01 Cr | ₹26.27 Cr |
| Profit Before Tax | ₹27.19 Cr | ₹13.61 Cr | ₹8.7 Cr | ₹6.58 Cr |
| Total Tax Expense | ₹7.87 Cr | ₹3.12 Cr | ₹2.76 Cr | ₹56.29 Lakh |
| Net Profit | ₹19.04 Cr | ₹11.75 Cr | ₹6.34 Cr | ₹6.02 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹236.83 Cr | ₹156.01 Cr | ₹87.08 Cr | ₹58.84 Cr |
| Non-current Assets | ₹97.31 Cr | ₹65.63 Cr | ₹35.1 Cr | ₹10.3 Cr |
| Current Assets | ₹139.51 Cr | ₹90.37 Cr | ₹51.97 Cr | ₹48.55 Cr |
| Property, Plant & Equipment | ₹42.58 Cr | ₹34.96 Cr | - | - |
| Inventories | ₹36.44 Cr | ₹28.24 Cr | ₹12.58 Cr | ₹7.17 Cr |
| Cash & Equivalents | ₹4.22 Cr | ₹2.46 Cr | ₹6.65 Cr | ₹13.77 Cr |
| Equity (Net Worth) | ₹96.68 Cr | ₹11.5 Cr | - | - |
| Current Liabilities | ₹87.89 Cr | ₹53.55 Cr | ₹20.26 Cr | ₹10.95 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Operating Cash Flow | ₹4.69 Cr | -₹10.24 Cr | ₹2.23 Cr | -₹17.44 Cr |
| Investing Cash Flow | -₹36.61 Cr | -₹13.82 Cr | -₹20.36 Cr | -₹6.94 Cr |
| Financing Cash Flow | ₹33.68 Cr | ₹19.76 Cr | ₹11.01 Cr | ₹38 Cr |
| Capital Expenditure | ₹36.47 Cr | ₹11.1 Cr | - | - |
| Free Cash Flow (computed) | -₹31.78 Cr | -₹21.34 Cr | - | - |
| Dividends Paid | ₹0 | ₹0 | ₹0 | ₹0 |
| Net Change in Cash | ₹1.76 Cr | -₹4.31 Cr | -₹7.13 Cr | ₹13.62 Cr |
| Metrics | Q3 FY26 | Q1 FY26 | Q1 FY25 |
|---|---|---|---|
| Revenue from Operations | ₹25.71 Cr | ₹23.61 Cr | ₹13.15 Cr |
| Other Income | ₹4.63 Cr | ₹1.35 Cr | ₹1.15 Cr |
| Total Income | ₹30.34 Cr | ₹24.96 Cr | - |
| Cost of Materials Consumed | ₹17.47 Cr | ₹11.78 Cr | ₹6.63 Cr |
| Purchases of Stock-in-Trade | ₹52.42 Lakh | ₹2.05 Cr | ₹83.19 Lakh |
| Changes in Inventories | -₹2.94 Cr | -₹2.89 Cr | ₹23.42 Lakh |
| Employee Benefit Expense | ₹2.53 Cr | ₹2.68 Cr | ₹1.1 Cr |
| Finance Costs | ₹1.24 Cr | ₹1.13 Cr | ₹49.37 Lakh |
| Other Expenses | ₹3.03 Cr | ₹4.81 Cr | ₹1.86 Cr |
| Total Expenses | ₹24.31 Cr | ₹21.02 Cr | ₹11.69 Cr |
| Profit Before Tax | ₹6.02 Cr | ₹3.93 Cr | ₹2.61 Cr |
| Total Tax Expense | ₹1.37 Cr | ₹1.15 Cr | ₹1.01 Cr |
| Net Profit | ₹4.3 Cr | ₹3.06 Cr | ₹2.29 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Revenue from Operations | ₹101.9 Cr | ₹67.8 Cr | ₹44.65 Cr | ₹31.69 Cr |
| Other Income | ₹4.17 Cr | ₹3.14 Cr | ₹2.2 Cr | ₹1.15 Cr |
| Total Income | ₹106.07 Cr | ₹70.94 Cr | - | - |
| Cost of Materials Consumed | ₹55.38 Cr | ₹32.86 Cr | ₹20.71 Cr | ₹12.19 Cr |
| Purchases of Stock-in-Trade | ₹8.85 Cr | ₹1.88 Cr | ₹9.52 Cr | ₹10.93 Cr |
| Changes in Inventories | -₹1.95 Cr | ₹1.47 Cr | -₹66.65 Lakh | -₹2.89 Cr |
| Employee Benefit Expense | ₹3.81 Cr | ₹3.07 Cr | ₹2.02 Cr | ₹1.61 Cr |
| Finance Costs | ₹1.66 Cr | ₹1.23 Cr | ₹46.3 Lakh | ₹46.59 Lakh |
| Other Expenses | ₹11.48 Cr | ₹11 Cr | ₹4.24 Cr | ₹3.61 Cr |
| Total Expenses | ₹81.09 Cr | ₹53.03 Cr | ₹37.06 Cr | ₹26.27 Cr |
| Profit Before Tax | ₹24.98 Cr | ₹17.91 Cr | ₹9.8 Cr | ₹6.57 Cr |
| Total Tax Expense | ₹6.89 Cr | ₹4.85 Cr | ₹2.76 Cr | ₹56.18 Lakh |
| Net Profit | ₹18.09 Cr | ₹13.05 Cr | ₹7.04 Cr | ₹6.01 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹159.19 Cr | ₹97.79 Cr | ₹73.24 Cr | ₹56.5 Cr |
| Non-current Assets | ₹49.13 Cr | ₹28.65 Cr | ₹20.26 Cr | ₹8.64 Cr |
| Current Assets | ₹110.06 Cr | ₹69.14 Cr | ₹52.98 Cr | ₹47.86 Cr |
| Property, Plant & Equipment | ₹18.27 Cr | ₹8 Cr | - | - |
| Inventories | ₹23.22 Cr | ₹16.57 Cr | ₹11.06 Cr | ₹7.17 Cr |
| Cash & Equivalents | ₹4.07 Cr | ₹2.11 Cr | ₹6.01 Cr | ₹13.77 Cr |
| Equity (Net Worth) | ₹95.36 Cr | ₹65.73 Cr | - | - |
| Current Liabilities | ₹52.38 Cr | ₹25.14 Cr | ₹16.91 Cr | ₹10.34 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Operating Cash Flow | ₹7.93 Cr | -₹3.49 Cr | ₹89.54 Lakh | -₹16.6 Cr |
| Investing Cash Flow | -₹20.07 Cr | -₹7.88 Cr | -₹11.01 Cr | -₹5.56 Cr |
| Financing Cash Flow | ₹14.1 Cr | ₹7.47 Cr | ₹2.35 Cr | ₹35.8 Cr |
| Capital Expenditure | ₹15.12 Cr | ₹5.21 Cr | - | - |
| Free Cash Flow (computed) | -₹7.19 Cr | -₹8.71 Cr | - | - |
| Dividends Paid | ₹0 | ₹0 | ₹0 | ₹0 |
| Net Change in Cash | ₹1.96 Cr | -₹3.9 Cr | -₹7.76 Cr | ₹13.64 Cr |
| Metrics | Q3 FY26 | Q1 FY26 | Q1 FY25 |
|---|---|---|---|
| Revenue from Operations | ₹23.67 Cr | ₹18.82 Cr | ₹14.74 Cr |
| Other Income | ₹89.21 Lakh | ₹53.65 Lakh | ₹47.29 Lakh |
| Total Income | ₹24.56 Cr | ₹19.35 Cr | - |
| Cost of Materials Consumed | ₹15.52 Cr | ₹11.45 Cr | ₹6.61 Cr |
| Purchases of Stock-in-Trade | ₹52.54 Lakh | ₹65.65 Lakh | ₹1.07 Cr |
| Changes in Inventories | -₹1.93 Cr | -₹1.85 Cr | ₹50.34 Lakh |
| Employee Benefit Expense | ₹78.98 Lakh | ₹86.99 Lakh | ₹52.18 Lakh |
| Finance Costs | ₹53.7 Lakh | ₹32.58 Lakh | ₹20.15 Lakh |
| Other Expenses | ₹2.49 Cr | ₹2.77 Cr | ₹1.96 Cr |
| Total Expenses | ₹18.64 Cr | ₹14.73 Cr | ₹11.19 Cr |
| Profit Before Tax | ₹5.92 Cr | ₹4.63 Cr | ₹4.02 Cr |
| Total Tax Expense | ₹1.91 Cr | ₹1.15 Cr | ₹1.01 Cr |
| Net Profit | ₹4.01 Cr | ₹3.48 Cr | ₹3.01 Cr |
Shareholding Pattern of Trident Lifeline Limited
As per the shareholding pattern filed with BSE for the quarter ended Mar 2026, promoters hold 62.85%, foreign institutional investors hold 7.24%, domestic institutional investors hold 0.27%, retail and other public shareholders hold 29.64% of Trident Lifeline Limited. The company had 607 shareholders on record.
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Promoters | 62.85% | 64.11% | 63.11% | 63.04% | 63.04% | 62.99% |
| Public | 37.15% | 35.89% | 36.89% | 36.96% | 36.96% | 37.01% |
| Mar 2026 | Mar 2025 | Mar 2024 | |
|---|---|---|---|
| Promoters | 62.85% | 63.04% | 67.48% |
| Public | 37.15% | 36.96% | 32.52% |
| Promoter change (YoY, %pts) | -0.19 | -4.44 | - |
Group Structure of Trident Lifeline Limited
Trident Lifeline Limited has 1 subsidiary company. This group structure data is as of FY 2023. The corporate group structure reflects Trident Lifeline Limited's business expansion strategy and organizational complexity.
| Company Name | CIN | Shares Held |
|---|---|---|
| Tns Pharma Private Limited | U24290GJ2021PTC128263 | - |
Showing major subsidiaries. Total: 1.
Charges & Borrowings of Trident Lifeline Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Nov 2025 | Others | ₹39.98 Lakh | Open |
| 27 Apr 2025 | Yes Bank Limited | ₹5 Cr | Open |
| 01 Mar 2025 | Yes Bank Limited | ₹2.5 Cr | Open |
| 01 Mar 2025 | Yes Bank Limited | ₹2.5 Cr | Open |
| 27 Feb 2025 | Yes Bank Limited | ₹16.53 Cr | Open |
Total charge records: 15 View all charges
Employees and EPFO Compliance at Trident Lifeline Limited
Trident Lifeline Limited has a workforce of 27 employees as of Apr 07, 2024.
Employee Count & EPFO Data of Trident Lifeline Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Trident Lifeline Limited
GSTIN & GST Filing Data of Trident Lifeline Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Trident Lifeline Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Trident Lifeline Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Trident Lifeline Limited
MSME Payment Delays by Trident Lifeline Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Trident Lifeline Limited
Subsidiaries & Group Companies of Trident Lifeline Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Trident Lifeline Limited with ownership details.
MCA Filings & Documents of Trident Lifeline Limited
MCA Filings & Documents of Trident Lifeline Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Trident Lifeline Limited
Recent News on Trident Lifeline Limited
Frequently Asked Questions about Trident Lifeline Limited
Trident Lifeline Limited is an active public limited company in the pharma sector based in Surat, Gujarat, India. It was incorporated on 09 January 2014 (12+ years old) and is registered under CIN L51909GJ2014PLC078227. The company has 27 employees.
Trident Lifeline Limited reported revenue of ₹46.71 Cr for FY 2024 (up 42.00% YoY).
The current directors of Trident Lifeline Limited are:
- Mishal Shailesh Patel
- Shravan H Patel
- Falguni Bhavesh Jariwala
- Hardik Jigishkumar Desai
- Rupaben Chetanbhai Jariwala
- Nikita Sharma
- Ashish Anandsingh Bafna
The primary industry of Trident Lifeline Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Yes, Trident Lifeline Limited is a listed company.
Trident Lifeline Limited can be reached at the registered office: 2Nd Floor Shop – 2004 North Extension Falsawadi Begumpura Nodh – 41650 Sahara Darwaja, Surat, Gujarat, India – 395003, or through the website tridentlifeline.com.